BioSpace News Archive

Tampa General Hospital announced that doctors at the academic health system had performed the first living donor liver transplant on the West Coast of Florida.

- $55 million equity financing closed - Resourced to advance lead drug candidate into clinical trials

Under the terms of the agreement, Viatris Japan will pay InDex an upfront fee of USD 10 million for the exclusive rights to commercialize cobitolimod in Japan. In addition

A collaborative effort of Florida Cancer Specialists & Research Institute, LLC (FCS) and CVS Health/Aetna to integrate cancer care advancements within a value-driven framework is delivering improved quality and cost savings for Medicare patients enrolled in the insurer’s Oncology Medical Home Program.

Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, will participate in a panel discussion on maximizing value in a capital efficient manner at the Sachs 9th Annual Immuno-Oncology Innovation Forum, taking place June 2, 2023 in Chicago.

Spero Therapeutics, Inc. announced that on May 25, 2023, the Compensation Committee of Spero’s Board of Directors approved the grant of an aggregate of 90,000 restricted stock unit awards to two new employees under the Spero Therapeutics, Inc. 2019 Inducement Equity Incentive Plan, as amended, or the 2019 Inducement Plan.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2023 Jefferies Healthcare Conference taking place June 7-9, 2023 in New York, NY.

Lexicon Pharmaceuticals, Inc. announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares of its common stock, par value $0.001.

GENFIT announced it has licensed the exclusive worldwide rights of ASK1 Inhibitor SRT-015 from Seal Rock Therapeutics, a Seattle, Washington based clinical stage company developing first-in-class and best-in-class kinase inhibitors.

Veeva Systems Inc., a leading provider of industry cloud solutions for the global life sciences industry, announced results for its first quarter ended April 30, 2023.